Rafina Innovations Financials
| VICA Stock | USD 0.0001 0.00 0.00% |
Rafina |
Please note, the presentation of Rafina Innovations' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Rafina Innovations' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Rafina Innovations' management manipulating its earnings.
Rafina Innovations Stock Summary
Rafina Innovations competes with LENSAR, Sight Sciences, STRATA Skin, EnVVeno Medical, and Bone Biologics. Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom. Rafina Innovations operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US75063R1068 |
| Business Address | Kintyre House, Glasgow, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | rafina-innovations.com |
| Phone | 44 1413 700 321 |
| Currency | USD - US Dollar |
Rafina Innovations Key Financial Ratios
Rafina Innovations' financial ratios allow both analysts and investors to convert raw data from Rafina Innovations' financial statements into concise, actionable information that can be used to evaluate the performance of Rafina Innovations over time and compare it to other companies across industries.Rafina Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rafina Innovations's current stock value. Our valuation model uses many indicators to compare Rafina Innovations value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rafina Innovations competition to find correlations between indicators driving Rafina Innovations's intrinsic value. More Info.Rafina Innovations is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Rafina Innovations by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rafina Innovations' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Rafina Innovations Systematic Risk
Rafina Innovations' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rafina Innovations volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Rafina Innovations correlated with the market. If Beta is less than 0 Rafina Innovations generally moves in the opposite direction as compared to the market. If Rafina Innovations Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rafina Innovations is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rafina Innovations is generally in the same direction as the market. If Beta > 1 Rafina Innovations moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Rafina Pink Sheet analysis
When running Rafina Innovations' price analysis, check to measure Rafina Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafina Innovations is operating at the current time. Most of Rafina Innovations' value examination focuses on studying past and present price action to predict the probability of Rafina Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafina Innovations' price. Additionally, you may evaluate how the addition of Rafina Innovations to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |